Name: DrAnand Govindaluri
Designation: Founder, Executive Director & CEO
Company: Govin Capital, Singapore & Startup Accelerator India Pvt Ltd
Linkedin
  web icon
Education:MBA (USA), MSC (Singapore), MSC (INDIA)
Summary: Dr Anand Govindaluri is the Founder & Chief Executive Officer of Govin Capital (govincapital.com), a Singapore-based early-stage investment company. He is also the Founder of Startup Accelerator India, Visakhapatnam, a technology accelerator focused on Digital Health & Technology that has expanded in Pune & Lucknow. Anand has 17 years of active investment management experience in the healthcare and technology sectors and is a recipient of Dr A.P.J. Abdul Kalam Award for Innovation & Entrepreneurship, by the Honourable Governor of Uttar Pradesh, India. Prior to GOVIN, Anand served as the Senior Vice President & Head of the Investment & Spin-Off Management Division at ETPL, A*STAR, Singapore (2009-2012). At ETPL, he led a team to manage a portfolio of 40 Startups from A*STAR in the fields of Medtech, Infocomm, & Engineering. In addition, he also actively organized several Technopreneurship & Investor workshops for researcher and scientific community in Singapore.

Prior to joining ETPL, Anand was a member of the Direct Investments Life Sciences team at Temasek Holdings, Singapore (2001-2009). At Temasek Holdings, Anand was active across the value-chain of investments in the healthcare arena – from deal sourcing, to conducting on-site due-diligence, negotiating term-sheets, serving on the boards of companies for strategic development and planning exit strategies. Some of the investments that he executed &/or served on the Board of Directors include – Merlion Pharma (Singapore), Biosensors International (Singapore), TauRx (Singapore), Quintiles (USA), Aptuit Inc (USA), Idun Pharma (USA; acquired by Pfizer), Agilix (USA; acquired by Perkin), Vical (USA), Intercell (Austria), Arpida (Basel), Elbion (Germany), BioVex (USA; acquired by Amgen), Renovo (Manchester), Dr Reddy Labs (India), Medreich (India; acquired by Meji Group, Japan), Matrix Labs (India; acquired by Mylan Labs) & Gleneagles Global Hospitals (Hyderabad). Anand is a Charter Member of TiE – largest community of entrepreneurs across the globe. He serves as a Board member for Cialfo (Singapore), eBeeCare (Singapore), Greenline Labs(India), CellBeans Healthcare Informatics (India), Palash IVF Solutions (India) & an Advisor Board member of Right Walk Foundation (India), Dr Kalam Centre (India). He was an Innovation Advisory member (Biomedical Sciences) of the Singapore-MIT Alliance for Research & Technology (SMART), Singapore (2011-2015). He has conducted Boot-Camps for Medtech Startups at IIT-Madras; Hyderabad Central University; i5 Summit organised by IIM Indore & IIT Indore; Startup Chile, i2i organized by IIM-Calcutta Innovation Park, Startup Singapore organized by NUS, Lee Kuan Yew Business Plan Competition organized by SMU, Singapore & Ideasinc.Sg Business Challenge organized by NTU, Singapore. Anand started his career as a researcher at AIIMS, leading medical institute in New Delhi, India. Anand received a Doctorate degree in Management (Honoris Causa) from KEISIE International University, South Korea; Master’s degree in Business Administration from California State University, East Bay, USA; Master of Science degree from The National University of Singapore, Singapore (NUS Overseas Post-Graduate Research Scholarship) and Master of Science degree in Molecular Biology & Biotechnology from G B Pant University, India (Department of Biotechnology, Government of India Scholarship). He also has a Certificate in IP Commercialization from The Global CONNECT University of San Diego, USA.

Entrepreneurship gives us a wonderdul opportunity to be an architect of not only our destiny but also that of a team who are completely aligned to a common goal. –Anand Govindaluri